Transdermal patch is a pharmaceutical paste patch that is positioned on the skin to transport a special amount of medicine through the skin into the blood circulation hence make it non- invasive way of drug delivery. Global transdermal drug delivery market was estimated at USD 22.0 Billion in 2010 and reached to at USD 32.0 Billion in 2015, registering a compound annual growth rate (CAGR) of 8.0%.
Based on the application, global transdermal drug delivery market is segmented are as follows:
While studying the global transdermal drug delivery market, we had segregated the market into:
On the basis of region, the global transdermal drug delivery market is segmented into:
Western And Eastern Europe
Row (Rest Of World)
Growth Drivers and challenges
On the back of factors like rising number of transdermal drug delivery products, enhanced awareness in developed nations about non-invasive way of drug administering drugs into body, increasing demand owing to its convenience over other conventional methods for supervising drugs etc. the transdermal patch drug delivery market is expected to have a greater demand in near future.
In addition to that, steep rise in diabetic population across the globe, advancement of technology in transdermal drug delivery and rise in the personal disposable income across the world are the factors which are anticipated to drive the growth of global transdermal drug delivery market during the forecasted period i.e. 2015-2021.
The global transdermal drug delivery market is restraint by high cost of the product, lack of awareness among in the developing and under-developed countries and availability of various alternatives in the market.
Market Size and Forecast
Global transdermal drug delivery market is estimated at USD 30.3 Billion in 2015 with 12.6% share accounted to the U.S. only; biggest market for transdermal drug delivery in the region. North American total drug delivery market was estimated at USD 518.2 Billion in 2015 and is anticipated to reach USD 752.6 Billion by 2021. Owing to rise in the demand of innovative drug delivery market in this region and growing acceptance of drug delivery technology by pharmaceutical and medical device companies are few of the factors that are projected to drive the transdermal patch drug delivery market in North America.
The European total drug delivery market was valued at USD 39.9 Billion in the year 2012 and it is anticipated that the transdermal drug delivery market will grow at a healthy rate over the forecasted period i.e. 2015-2021 owing to the increasing demand for self-administration and home healthcare devices.
Asia pacific transdermal drug delivery market is projected to grow at a substantial rate owing to a steep rise in medical tourism in the region, world-class medical facilities and medical procedures at a low cost, rising incidents of chronic diseases like cardiovascular diseases, diabetes, cancer etc.
The key player of the global transdermal drug delivery market is as follows:
ANI Pharmaceuticals Inc.
Antares Pharma Inc.
Janssen Pharmaceuticals Inc.
Scope and Context
Overview of the Parent Market
Market Size and Growth
North America (U.S., Canada)
Latin America (Mexico, Brazil, Rest of Latin America)
Western and Eastern Europe (Germany, Italy, Spain, France, U.K, Benelux, Hungary, Rest Of Western Europe, Russia Poland, Rest of Eastern Europe)
Asia-Pacific (China, India, Singapore, Japan, Australia & New Zealand & Rest of Asia)
Middle East and North Africa (MENA)
Rest of World
Supply & Demand Risk
Porter’s Five Force Model
Geographical Economic Activity
Key Players (respective SWOT Analysis) and their Strategies and Product Portfolio
Recent Trends and Developments
Industry Growth Drivers and Challenges
Key Information for Players to establish themselves in current dynamic environment
To know more about this research, kindly visit: http://www.researchnester.com/reports/global-transdermal-drug-delivery-market-analysis-opportunity-outlook-2021/111
For Table of Content & Free Sample Report Contact:
U.S. +1 646 586 9123
U.K. +44 203 608 5919